Kenvue Inc. logo

Kenvue Inc. (KVUE)

Market Closed
17 Apr, 20:00
NYSE NYSE
$
23. 39
+0.66
+2.9%
$
36.11B Market Cap
21.62 P/E Ratio
0.8% Div Yield
22,595,700 Volume
1.14 Eps
$ 22.73
Previous Close
Day Range
22.72 23.53
Year Range
17.67 24.46
Earnings results expected in 14 days

Summary

KVUE closed Thursday higher at $23.39, an increase of 2.9% from Wednesday's close, completing a monthly decrease of -2.62% or $0.63. Over the past 12 months, KVUE stock gained 8.69%.
KVUE pays dividends to its shareholders, with the most recent payment made on Feb 26, 2025. The next announced payment will be in In 1 month on May 28, 2025 for a total of $0.205.
The last earnings report, released on Feb 06, 2025, missed the consensus estimates by -0.05%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on May 05, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track KVUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

KVUE Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Kenvue Inc. (KVUE) FAQ

What is the stock price today?

The current price is $23.39.

On which exchange is it traded?

Kenvue Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is KVUE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 36.11B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on May 05, 2025.

Has Kenvue Inc. ever had a stock split?

No, there has never been a stock split.

Kenvue Inc. Profile

Household & Personal Products Industry
Consumer Defensive Sector
Mr. Thibaut Mongon CEO
NYSE Exchange
US49177J1025 ISIN
US Country
22,000 Employees
14 May 2025 Last Dividend
- Last Split
4 May 2023 IPO Date

Overview

Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.

Products and Services

  • Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
  • Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
  • Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.

Contact Information

Address: 199 Grandview Road, Skillman, NJ, United States, 08558
Phone: 908-874-1200